Last reviewed · How we verify
Dexmedetomidine and Midazolam — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Dexmedetomidine and Midazolam (Dexmedetomidine and Midazolam) — Montefiore Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dexmedetomidine and Midazolam TARGET | Dexmedetomidine and Midazolam | Montefiore Medical Center | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dexmedetomidine and Midazolam CI watch — RSS
- Dexmedetomidine and Midazolam CI watch — Atom
- Dexmedetomidine and Midazolam CI watch — JSON
- Dexmedetomidine and Midazolam alone — RSS
Cite this brief
Drug Landscape (2026). Dexmedetomidine and Midazolam — Competitive Intelligence Brief. https://druglandscape.com/ci/dexmedetomidine-and-midazolam. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab